Researchers cast doubt on role of homocysteine in predicting heart disease
This article was originally published in Clinica
A new study has thrown into doubt the role of the amino acid homocysteine in heart disease. Many manufactures market homocysteine tests to assess the risk of heart disease and some experts have predicted the market for the tests to overtake that of cholesterol tests.
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.